November 13, 2025
MS-DETECT and clinical standards at CHARCOT
At the CHARCOT Congress held in November 2025 in Baveno, Italy, we highlighted the importance of remote symptom assessment with MSCopilot®.
Our study demonstrates a correlation between our medical device and standard clinical scores in Multiple Sclerosis (MS) patients. The device enables home measurement of essential disease functions.
Furthermore, its global score significantly correlates with MSFC-4, underscoring its potential as an MS monitoring tool in real-world conditions.